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Inaccurate, untimely, and miscommunicated medical diagnoses represent a wicked problem requiring 
comprehensive and coordinated approaches, such as those demonstrated in the characteristics of 
learning health systems (LHSs). To appreciate a vision for how LHS methods can optimize processes and 
outcomes in medical diagnosis (“diagnostic excellence”), we interviewed 32 individuals with relevant 
expertise: 18 who have studied diagnostic processes using traditional behavioral science and health 
services research methods, 6 focused on machine learning (ML) and artificial intelligence (AI) 
approaches, and 8 multidisciplinary researchers experienced in advocating for and incorporating LHS 
methods, i.e. scalable continuous learning in health care. We report on barriers and facilitators, 
identified by these subjects, to applying their methods toward optimizing medical diagnosis. We then 
employ their insights to envision the emergence of a learning ecosystem that leverages the tools of each 
of the three research groups to advance diagnostic excellence. We found that these communities 
represent a natural fit forward, in which together, they can better measure diagnostic processes and 
close the loop of putting insights into practice. Members of the three academic communities will need 
to network and bring in additional stakeholders before they can design and implement the necessary 
infrastructure that would support ongoing learning of diagnostic processes at an economy of scale and 
scope. 
Keywords: medical diagnosis, diagnostic error, machine learning, learning health systems, 
multidisciplinary, learning community  
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In its breakthrough 2015 report, Improving Diagnosis in Health Care, the National Academy of Medicine 
(NAM) argued for new approaches for health care organizations to “identify, learn from, and reduce 
diagnostic errors and near misses in clinical practice.”1 This is but one of several publications 
documenting the extent of missed, delayed, and miscommunicated diagnosis as a cause of unnecessary 
morbidity and mortality.2–7 However, because diagnostic processes are difficult to objectively measure, 
diagnostic quality and safety efforts have largely been eclipsed within the patient safety movement by 
treatment errors.8  As such, diagnosis has assumed the status of a systemic and persistent “wicked 
problem” for health and health care.9   
Over the past decade, since the introduction of the concept by the (then) U.S. Institute of Medicine,10 
the Learning Health System has emerged as a method for addressing large scale health challenges.11 The 
potential of applying Learning Health System (LHS) methods to address the wicked problem of 
diagnostic error motivated program officials of the Gordon and Betty Moore Foundation to suggest an 
exploratory study of how this connection might be achieved, and more specifically, how the 
characteristics of a functioning learning health system11 can support the cultural and technical changes 
required to pursue diagnostic excellence. In particular—through the mandate to learn from every 
patient and their health experiences12,13 and through the infrastructure-supported ability to rapidly 
deliver new knowledge into practice12—there are sound reasons to believe that LHS approaches hold 
the potential to catalyze efforts toward accurate and timely diagnoses. 
The NAM report on diagnostic error outlines broad goals to address the infrastructural, procedural, and 
cultural pitfalls that are perpetuating these errors in health care.1 In doing so, it lightly alludes to the 
coordinated, system-based approach that LHS’s can offer such a deeply systemic problem.14 
With support from the Gordon and Betty Moore Foundation, we explored the collaborative potential to 
apply learning health system approaches toward diagnostic ‘excellence’: a term that goes beyond 
reducing error and encompasses optimizing the often competing factors of timeliness, cost, and patient 
experience. Resting on the precept that multi-stakeholder learning communities are fundamental to the 
LHS concept, we explored how three, distinct academic disciplines, guided by differing sets of 
underpinning sciences and associated methods, might interact to further the promotion of diagnostic 
excellence. How have (or haven’t) these communities interacted thus far, and how can weaving them 
together create a stronger approach to this wicked problem?  
The first community comprises researchers and advocates for improving diagnosis (IDx), a group that 
largely utilizes methods associated with clinical research informed by behavioral and cognitive sciences. 
Concerns with diagnostic error and delay have gradually garnered the attention of researchers, 
beginning with (though somewhat overshadowed by) patient safety movements in the mid-
1990s.2,4,8,15,16 Towards the end of the first decade of the 21st century, leading researchers in diagnostic 
error began to form a more organized coalition, resulting in the formation of the Society to Improve 
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Diagnosis in Medicine (SIDM). SIDM has successfully advocated for greater attention to diagnostic 
errors, in particular by charging the National Academy of Medicine to create the Improving Diagnosis in 
Health Care report.1 Concurrently, diagnostic researchers have focused heavily on defining the size and 
scope of the diagnostic error problem,2,3,17 creating taxonomies of cognitive and systemic causes,2,18–21 
and testing interventions for identifying and reducing specific types of errors.22–25 Supported by this 
forward momentum, it appears that the IDx movement is poised to make a large impact if systemic, 
coordinated infrastructure with broad utility for quality improvement delivery is put in place. 
Our second community of focus concerns researchers in machine learning and artificial intelligence 
(ML/AI) in health care. These computer scientists, in collaboration with clinicians, use complex medical 
data—including from electronic health records (EHRs), medical imagery, sensors, and genomes—to 
create inferences that can be used to improve care. The Moore Foundation charged us with exploring 
how these tools might catalyze diagnostic improvements—a supplemental, 21st century counterweight 
to the cognitive biases that occur during diagnosis. Recently, ML/AI researchers have made headlines 
with tools that can diagnose certain conditions with higher positive predictive values than the average 
clinician.26–28 However, although the appropriate use of AI in health care is frequently debated within 
medical literature,29–35 there is little published attention to how any given tool can be used in the clinic. 
It is clear that the ML/AI community has a place in pursuing diagnostic excellence, but the exact dynamic 
of this intersection remains unclear.  What is certain is that this goal requires ML/AI stakeholders who 
understand the dynamics of collaborating with physicians and other clinical experts. 
The third community encompasses LHS researchers and implementers, a group comprising a mélange of 
biomedical informatics and system, policy, and implementation sciences. Members of this group use 
their diverse backgrounds and experiences to advocate for health system reform that incorporates 
scalable continuous learning that can be applied to any health problem. We hoped to leverage their 
expertise to illustrate how to improve diagnostic outcomes at broader scale and scope than could 
previously be completed. Furthermore, we proposed that the LHS methods employed by this 
community could provide a framework for the intersection of the IDx and ML/AI communities. We ask, 
how can systems better link knowledge generated by ML/AI researchers and the much needed changes 
to clinical practice, championed by the IDx movement?  
This paper reports the initial step in generating a mature vision of an LHS approach toward diagnostic 
excellence endorsed by diverse stakeholders. We designed the project in two phases. The first phase, 
reported here, explored the interests and perspectives of three contributing research communities: 
members of the IDx community, researchers applying ML/AI to health care, and LHS researchers. We 
accomplished this via 32 key-informant interviews, designed to capture the landscape of the three 
research communities and insights into their potential for interaction. The second phase, the results of 
which will be described in a separate publication, convened multidisciplinary collaborators at a two-day 
meeting. 
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We designed our research questions to inform a meeting of all three research communities around the 
aim of diagnostic excellence. To fully envision how all three communities can contribute to diagnostic 
excellence, we broke our aim into three questions that each provide valuable context to understanding 
a potential collaboration. First, we sought to understand the landscape of each community by defining 
both its history and trajectory toward collective goals, as well as the barriers and facilitators to meeting 
those goals. Second, we contextualized the activities of each community as they relate to the LHS 
construct that new knowledge can and should be rapidly translated into practice, asking how each 
community approaches, promotes, or facilitates translation and dissemination of findings into clinical 
practice. Finally, so that we could be aware of and account for the interdisciplinary dynamics, we 
needed to discern each community’s level of understanding of and attitudes toward the two other fields 
in this potential collaboration.  
Method 
Key-Informant Selection 
Our key-informant interviews comprised 32 experts dedicated to improving diagnosis (n=18), ML/AI in 
healthcare (n=6), and Learning Health Systems (n=8). Informants were contacted by the principal 
investigator (CPF) via e-mail explaining the project and inviting them to schedule an interview via phone 
or in-person at the 2017 Diagnostic Error in Medicine (DEM) Conference in Boston, MA. We identified 
informants from each community as follows: 
Diagnostic Improvement. We contacted the primary investigator from each grant in the Gordon and 
Betty Moore Foundation’s Diagnostic Excellence investigative program (n=9). Additionally, we spoke 
with a leader in SIDM to expand our list to include other key researchers and patient advocates (n=9). All 
18 informants agreed to be interviewed about their field, 7 of whom were interviewed in-person at 
DEM. 
Machine Learning and Artificial Intelligence in Health Care. To identify ML/AI researchers who might be 
interested in this project, we connected with a colleague who is a leader in the Machine Learning for 
Healthcare conference group. We reviewed titles and abstracts presented at their 2017 meeting to 
create a shortlist of researchers who might be interested in machine learning in ambulatory diagnosis 
and/or demonstrate interdisciplinary collaboration. We contacted nine researchers, six of whom 
responded to the invitation and then scheduled an interview.   
Learning Health Systems. We drew on our extensive network of learning health systems professionals 
to identify a list (n=8) of researchers and advocates who focus on a broad array of approaches and 
concerns in developing learning health systems. All of the identified individuals agreed to the interview. 
Interview Procedure and Guides 
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Interviews were semi-structured, approximately 30 minutes in duration, and adaptable to the 
interviewees’ insights and direction. The interviewer first offered a summary of the project and asked 
permission to record for note-taking purposes. 
We created a separate interview guide for each community of study (full interview guides can be found 
in the supplementary material). Interview guides began with an in-depth focus on the interviewees’ own 
discipline: learning about their research journeys as a proxy for the history and trajectory of their fields. 
We generally surveyed their discipline’s significant accomplishments, important questions, and major 
needs or barriers. 
Later questions addressed our second and third research questions, inviting thoughts on the potential 
for collaboration among these three research communities. Through this stage of the interview, we 
gauged familiarity with and attitudes toward learning health system concepts and how they could relate 
to diagnosis. For example, we asked how each discipline approaches translating knowledge into practice 
and implementing lessons learned. Additionally, we prompted interviewees to respond to the idea of 
using ‘big data’ and/or machine learning  to assist with problems related to medical diagnosis. These 
open-ended questions were designed to spur insights into the dynamics at play before we planned a 
convening of interested parties.  
Because the interviewer was a representative of LHS researchers, special care was taken to demonstrate 
neutral positions, prevent leading questions on the functions and goals of LHSs (unless requested after 
LHS-related prompts had been discussed), and invite open dialogue. Following the discussion, we 
encouraged interviewees to contact us with any further thoughts. All interviewees were invited to join 
us for the meeting in phase two, which was designed around the results from these interviews. 
Analysis 
Interviews were recorded concurrently with notetaking in Microsoft OneNote, which enables 
timestamped playback for review of each new line of text. During the conversation, the interviewer 
grouped notes according to over-arching concepts in the interview guide. These varied slightly for each 
of the three disciplines, but were roughly divided into groups representing the interviewee’s discipline, 
followed by distinct sections for perceptions of and interactions with the other two research 
communities. After each encounter, the interviewer reviewed gaps in the notes, summarized 
information collected, and highlighted insights into interdisciplinary dynamics and insights into the 
fields, assisted by the time-stamped recording.  
Once collected data approached saturation and/or all scheduled interviews were complete, we initiated 
formal analysis of the complete interview notes from each discipline. We iteratively reviewed interview 
notes with an inductive approach to build a thematic analysis. Using the list-making web-application 
Trello, we organized and analyzed data into themes, which in turn were categorized into four domains 
that emerged as a high-level synthesis of the questions asked of each individual community. The results 
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are presented according to these domains: work on diagnostic excellence, ML/AI in healthcare and for 
diagnostic excellence, LHSs and their application for diagnostic excellence, and clinical translation. To 
assist interpretation of themes in the context of potential collaboration, all themes were also tagged to 
mark tensions, open questions, and the discipline(s) that addressed the theme during interviews. Finally, 
throughout interpretation, we were mindful of potential biases that may have occurred in the 
interviews because the interviewer was a representative of established LHS researchers.  
Results 
General Perspectives on Pursuing Diagnostic Excellence 
The IDx researchers are proud of the community they have established over the last decade and of 
subsequent achievements that have put diagnostic harm on the radar as a significant patient safety 
concern. Despite this growing momentum, interviewees in the ML/AI and LHS communities were 
relatively unfamiliar with the diagnostic improvement space, signaling the need for continued visibility 
of the IDx community and movement. In a similar vein, IDx interviewees generally agreed that because 
the diagnostic process is much less visible than medical treatment, diagnostic error must be addressed 
separately from traditional quality and safety approaches. Without this separation, they argued, it is 
likely that diagnostic error will continue to remain in the background of more highly visible, measurable 
opportunities to prevent iatrogenic harm and optimize therapeutic outcomes. This view is accompanied 
by a general sense that their community does not agree on the definition and scope of diagnostic error 
and have mixed approaches to propelling the movement forward. However, they agreed on a number of 
barriers  that prevent the full integration and acceptance of diagnostic excellence as a critical 
component of safe and quality care. 
Data and Measurement Barriers to Diagnostic Excellence. IDx experts frequently emphasized the need 
to standardize and tighten the feedback loop that informs care providers of distal diagnostic outcomes 
of patients. As one interviewee quipped, “If an individual doctor makes a diagnosis and doesn’t ever 
hear that the patient turned out to have a different diagnosis and got re-admitted, or it turns out their 
diagnosis was wrong, then [the doctor] will never get better.” IDx participants commented on the 
inherent difficulty gathering this data if the correct diagnosis is made by another clinician or, even more 
so, in another health system. As a response, many seek ways to better engage the patient who has the 
power to “tell us if we got something right.”  
This need for feedback is predicated on the need for measures that both define and track error. One 
interviewee recalled research that found that harm from diagnostic error is often identifiable among 
patient safety reports, but not consistently mapped to diagnostic error as the root cause. This issue 
compromises efforts to form healthcare organizations’ (HCOs) “business case” for creation and 
implementation of improved diagnostic measures. One participant called for public accountability 
efforts similar to those for patient safety, which might create the necessary pressure on HCOs. These 
interviews did not reveal deeper insights into how to gain commitment from HCOs, though barriers 
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were largely presumed to be fiscal. However, one interviewee hypothesized that difficulty in funding 
research in diagnostic error may also be impeded by clinicians who review funding opportunities, as 
they may feel criticized by the notion that they and their peers are not diagnosing patients adequately.  
Behavioral Barriers to Diagnostic Excellence. In that regard, many interviewees referenced various ways 
that clinicians may inadvertently impede diagnostic improvement. Experts cautioned that physicians 
don’t have the tools to self-assess diagnostic skills. One clinician spoke about approaching doctors to 
think about this problem: “A lot of them have their hackles go up when you start talking about error. 
They all know about it because they all know about malpractice and the risk of malpractice, but they all 
think it's somebody else that's not as good as them, or not as careful, or not as well trained.” The 
interviewees who spoke about this issue cited several drivers, rooting the cause in medical school, which 
they said often lacks adequately explicit training in the diagnostic process even while emphasizing the 
importance of clinical reasoning. Instead, diagnostic processes are treated as “private mental events” in 
the head of an expert (i.e. physician) who does not need to document an explanation. Furthermore, the 
prevailing culture promotes the idea that doctors can and should memorize all medical knowledge, 
upholding a social norm that to need to reference secondary sources is a sign of incompetence. 
Interviewees argued that these cultural factors cause physicians to miss opportunities for patients to be 
better served with consults from other doctors or use of diagnostic support systems.  
This barrier is perhaps exacerbated by sub-optimal data from physical exams and patient history. The 
physicians we interviewed desire more comprehensive, longitudinal health data that would enable more 
rigorous interactions with relevant health history. Together with other behavioral changes, this could 
potentially improve bedside diagnostic processes, including history-taking, physical exams, test selection 
and interpretation, and development of the differential diagnosis. However, current weaknesses are 
ambiguously attributable to both clinician procedure and EHR design that might inhibit accurate data 
recording. 
General Perspectives on Machine Learning/Artificial Intelligence in Health Care and its Potential 
Application toward Diagnostic Excellence 
The six computer scientists we interviewed in the ML/AI community have recently applied a variety of 
methodologies toward improving healthcare delivery and administration. These approaches range in 
scope and area of effort. Some use Natural Language Processing (NLP) to synthesize relevant 
information from journal articles and electronic health records (EHRs) for a clinical team’s immediate 
use. Others leverage predictive modelling and causal inference to make highly generalizable conclusions. 
Still others described how they can use control theory/Q-learning/back propagation techniques to 
identify pivot points or errors in a clinical pathway. In all cases, their research interests are grounded in a 
desire to answer complex questions through data, and the healthcare domain poses unique challenges 
that influence their approach. They advocated collaborating directly with clinicians on questions of 
causality, rather than simply increasing the accuracy of a prediction. One ML/AI researcher pointedly 
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observed, “I care more about action-ability and lead time than positive predictive values.” This is echoed 
in a set of guiding characteristics that another researcher identified through direct work with clinicians: 
that models must be actionable, or have utility in practice; that they are robust as clinical conditions and 
context change; and that models should be made more credible by leveraging what is already known 
from the literature. 
A critical component of integrating ML/AI methods with healthcare is establishing meaningful and 
mutually beneficial collaborations among researchers, clinicians, and others involved in the care 
process. As one researcher pointed out, “Because of the nature of the type of research we do . . . we 
have to have work used. . . . It is as hard as coming up with machine learning techniques.” This 
researcher stressed relationship building and sometimes doing “service” work with health systems 
contacts on questions that are less academically interesting in order to support this process. Other 
experts have sought collaborations in more integrated ways, such as by bringing physicians into their 
labs as colleagues and by training physicians as doctoral students in computer science. Overall, these 
approaches have helped computer scientists identify clinically relevant questions, conduct clinically 
accurate analyses, and obtain access to data. The latter has been historically challenging for computer 
scientists. “Shareable data,” one researcher said, “have been key to allowing researchers to really 
benchmark their data and risk-stratification algorithms, which has led to significant advancements.” 
However, there are still difficulties implementing their results into clinical settings. A few researchers 
described licensing their algorithms to third-party companies as an avenue to put these products into 
meaningful practice, though one recounted being rebuffed by a major producer of digital medical 
products that did not want to undertake the FDA approval process.  
Potential Collaboration. Recognizing that this sample is limited to six ML/AI computer scientists and 
eighteen diagnostic researchers, evidence emerged from these interviews that the ML/AI and IDx 
communities have not deeply interacted. Of particular importance, the computer scientists did not 
readily offer many examples of ML/AI work specific to medical diagnosis. Two of these researchers very 
vocally emphasized addressing treatment over diagnosis, believing that physicians are not interested in 
diagnostic support and that the potential impact is not worth the effort. In the words of one researcher, 
“Interesting questions lie in the iterative improvement of the treatment plan, rather than in the 
diagnostic process.” 
On the other side of the collaboration, IDx researchers acknowledged the potential to apply “big data” 
and ML/AI techniques to their field, but also expressed significant apprehension. First and foremost, 
they were concerned about the quality of available data. As (many of them) physicians, they understood 
firsthand the unreliability of billing data and free text in the EHR, questioning the validity and utility of 
any conclusions made from those sources. Some expressed general skepticism about the value of these 
methods beyond existing achievements in imaging-related fields such as radiology, dermatology, and 
pathology.  
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Many of the IDx researchers asserted that any ML algorithms that might be applied to healthcare must 
be designed to be understandable by the clinicians making care decisions. The underlying tension on this 
point was echoed by members of the other two communities. To one computer scientist, this means 
creating a dialogue to counter the “myth that AI algorithms are black boxes.” This was corroborated by 
an LHS interviewee with decades of work on diagnostic support tools, who emphasized that providing 
explanations for “black box” algorithms is critical to engendering trust in ML/AI methods. Other LHS 
researchers, however, proposed more broad solutions through building interactive, interpretable 
systems where knowledge is intentionally rendered in a form in which clinicians can review, edit, and 
disseminate it. Additionally, one IDx physician argued that the unknown consequences of AI in 
healthcare demand that stakeholders develop a certification process for algorithms’ use in the 
healthcare setting. Regardless of the approach, it seems clear that application of ML and AI methods 
toward diagnostic excellence requires increased dialogue between interested parties. This dialogue 
would both create awareness of mutual interests and build consensus on the scope of this proposed 
intersection.  
General Perspectives on Learning Health Systems and their Potential Application toward Diagnostic 
Excellence 
In interviews with LHS experts, we found that it can be difficult to adequately discuss the potential for 
LHS-based solutions when current examples are typically scaled to single health systems and not fully 
mature. At the same time, interviewees expressed belief that implementation of small-scaled LHSs 
remain an important stepping-stone toward interoperability on a much larger scale. For example, one 
expert spoke of securing buy-in to LHS methods: “It's a concept, I know, that polarizes people. And what 
would really help in terms of moving this on is if we could at least in a couple of areas build up some 
genuine exemplars that have the potential to scale.” Building these exemplars would concretely 
demonstrate feasibility, generate data on the persistence and effects of the organizational learning that 
occurs, and attract more adopters of an LHS model.  
Furthermore, LHS interviewees agreed that technical issues were not the major challenge to LHS 
development. A former computer scientist from the LHS community stated: “[emergence of a large scale 
LHS] was unlikely to be achievable using traditional software and systems engineering thinking and 
[their own ideas were] more focused on establishing conditions under which the right sorts of 
infrastructures and dynamics would emerge.” In other words, the development of larger scale systems is 
contingent on incentivizing cooperation between and within stakeholders in the health industry.  
Similarly, a common theme between LHS interviews highlighted the necessity to form a sociotechnical 
system solution that links the efforts and interests of all stakeholders at multiple points in a care 
pathway to address system-level changes and concerns. One LHS expert emphasized that future success 
is dependent on whether, “the culture of the care process is one in which decisions are made in a team 
fashion rather than in a linear, traditional, clinician-to-patient unidirectional fashion.”   
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Potential Collaboration. Overall, results of interviews with eight LHS experts reflected the 
interdisciplinary background of this diverse group of researchers and advocates, including former 
physicians, computer scientists, and individuals with expertise in health information technology, health 
policy, and population health. As such, their perspectives echoed many themes expressed by the IDx and 
ML/AI communities, incorporating calls for actionable algorithms, shared data, and clinician feedback. In 
general, they offered a visionary roadmap for systems changes, promoting the potential of LHS 
approaches to provide context in rapidly advancing health care. As one leader put it, “We could 
significantly tailor diagnostic tools more appropriately to the individual circumstances, and part of it will 
emerge through development of decision tools that will help individual clinicians contend with the fact 
that knowledge availability and knowledge needs far surpass the human capacity.”    
When questioned about adapting LHS approaches to diagnostic problems of interest, one former 
physician-turned LHS advocate expressed excitement over the untapped opportunity of accessing 
‘breadcrumbs’ in the EHRs for cracking diagnostic problems that run over long periods of time. Although 
this feasibility of using EHR data was common among all three communities, this proposal was relatively 
unique among the LHS group, in part for its tailoring to the needs of the diagnostic process. In contrast, 
a few LHS researchers pointed out that their field is domain-agnostic, and they dismissed potential 
disciplinary challenges in using LHS approaches for diagnosis. This tendency is visible across insights 
from the LHS interviews, which are frequently centered on LHS perspectives rather than anything 
specific to diagnosis. On further reflection, one interviewee acknowledged that “diagnosis is a process 
that perhaps has more uncertainty”—and more complexity on the K2P side of the learning health 
cycle—compared to other LHS applications and earlier automated decision support systems (such as 
what is used for drugs). With this in mind, the researcher went on to describe the potential 
collaboration of these three communities as the ‘poster child’ for how learning health infrastructures 
must complement existing human-completed processes. In other words, full automation is not a viable 
option. 
On that note, members of the IDx group generally supported the concept of LHS’s for diagnostic 
excellence, particularly by endorsing organizational-level learning and improving. Some ML/AI 
researchers optimistically viewed LHS’s as an avenue to better incorporate patient histories and 
diversity into our standard of care (compared to the standard of learning from randomized clinical 
trials). Overall, responses from the two other domains were neutral or positive, though only a few IDx 
experts had a strong conceptual grasp of LHS’s as cultural and infrastructural endeavors (rather than as 
single, isolated feedback loops). These interviewees could comfortably integrate their actionable 
agendas for diagnostic improvement into LHS scope and scale. 
Clinical Translation 
Finally, responses to our questions about translating research into practice highlighted the potential 
benefit that LHS approaches can offer the diagnostic problem space. Expressing frustration with “all 
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these papers and no uptake,” a few IDx interviewees discussed interest in wrapping multidisciplinary IDx 
researchers into a health care organization to directly link research and clinical practice. However, as 
pointed out by some interviewees in multiple communities, there are high-level policy-level and cultural 
changes that would need enacted before this could become routine. “We need to develop a clear 
societal understanding,” an LHS researcher said, “that we expect systems to learn from practice they do 
and to share that info without running afoul of [the] oversight regime that covers research.” However, 
the future of how we distinguish traditional clinical research and iterative health system learning 
remains unclear, and these interviews did not offer a roadmap toward a solution.  
Discussion 
Piecing Together the Collaboration—Themes and Insights from the Interviews 
Many of the themes derived from the interviews illustrated that these three communities are 
compatible—if not ripe—for deeper collaboration. In reviewing the results of the interviews, we quickly 
realized a natural fit, in which the expertise of the three communities loosely correspond to a high level 
abstraction of a learning health system: the learning cycle (depicted in Figure 1). The learning cycle is 
represented by three stages, initiated when a learning community organizes around a problem of 
interest. They collect performance and health outcomes as analyzable data (performance-to-data 
[P2D]); data is analyzed into new knowledge, or insights about the problem or how to address it (data-
to-knowledge [D2K]); knowledge is strategically directed into changes in health practice (knowledge-to-
performance [K2P]), and the cycle starts again at P2D.11    
The IDx community has spent a few decades building strong research programs to further define the 
scope and causes of harms from diagnostic error. However, the experts we interviewed cited their 
persistent difficulty seeking to learn from every patient and health event. In particular, they desired data 
collection of distal patient outcomes, including indicators of diagnostic performance that are recorded 
by other physicians or other health systems. Although they have laid the building blocks for P2D, and 
continue to create standardized measures of diagnostic processes,36–38 partnering with LHS thinkers 
could potentially improve linkages across systems. This would also improve quantity and representation 
of currently collected measures.39 For instance, certain rare diseases or atypical presentations of 
common diseases may not have sufficient incidence (even in regional health networks) to supply 
sufficient statistical power to learn about and improve the rate of timely and accurate diagnosis.24 The 
solution to this problem—sharing large amounts of data across health systems—has the potential not 
only to increase power for a particular condition, but also increase power for understanding the effects 
of demographic and socio-economic characteristics. To take a drug safety surveillance analogy, at a 2013 
conference on data-driven healthcare decision-making, Dr. Larry Norton noted that it took the FDA over 
five years to recognize that the drug Vioxx was causing a significant increase in fatal myocardial events 
and withdraw it from the market. In a health data-sharing network comprising 8 million patients, a 
safety signal could have been detected in under half that time. With 150 million patients represented, it 
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would have taken under 6 months, and if the entire nation were sharing data, the signal would have 
been realized in under ten weeks.40 Networked systems with data-sharing are requisite to fully and 
rapidly learn from and for all patients.30,41,42 
Furthermore, the IDx and ML/AI groups are critically disconnected, slowing the introduction of new 
analytic (i.e. D2K) methods that might reveal diagnostic breakthroughs.34,39 These innovative methods, 
especially when accompanied by new measurements of diagnostic process, offer more than high-
performing predictive diagnostic algorithms. They could also facilitate diagnostic excellence by providing 
insights into the balance between diagnostic accuracy, timeliness, cost, and patient experience. 
However, these aspirations cannot be realized without tightly-knit collaborations between clinical 
stakeholders and the researchers who can build such tools. As we heard in interviews from all three 
communities, clinicians are generally not interested in tools that predict a diagnosis. To overcome 
cultural barriers, clinical and research stakeholders need to create sociotechnical diagnostic support 
processes that encourage and offer consultation. Although research on uptake is relatively slim,43 we 
can see this with the current generation of diagnostic support software, such as VisualDx and Isabel, 
which give clinicians tools to explore symptoms and probable diagnoses. 
Finally, health systems are not designed in a way that properly promotes uptake of diagnostic best 
practices into clinical practice (i.e. K2P). Although this barrier was not frequently stated in interviews 
with IDx experts, it is implicit in the historical difficulty in bringing attention to and improving 
diagnoses.1,8 As our LHS interviewees commented, we are in desperate need of system-based solutions 
that catalyze K2P, institutionalizing the pipeline—curation, management, and dissemination—that 
translates evidence-based medicine and machine learning algorithms into the clinical exam room.31,44 
Perhaps most importantly, interviewees in all groups called for multi-stakeholder engagement. The 
involvement of stakeholders from clinical, computer science, and systems and implementation science 
disciplines—plus the critical voice of patients—will engender shared appreciation for the strengths and 
limitations of methods to create lasting changes in diagnostic quality.32,33,36 This collaboration also has 
the potential to build a solid LHS exemplar to further the vision for other health questions. Together, 
these groups can create and sustain the systemic solutions needed to create diagnostic excellence.  
Limitations 
The design of this project limited the scope and perspective of the results. Interviewees may have had 
social and professional incentives to speak favorably when discussing potential collaborations. More 
directly related to the prospects of a future LHS for diagnostic excellence, the scope of the project was 
limited to three broad domains that were commonly grounded in academic relationships. Any practical 
next steps would need to include stakeholders that were not specifically brought into this discussion, 
such as patients, caregivers, and their advocates; HCOs and the policy, administrative, and legal 
perspectives that support them; a range of clinical professionals involved in diagnostic processes; 
additional implementation science experts; and quality and safety organizations.  
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Steps Toward a Learning Ecosystem for Diagnostic Excellence 
The vast and complex scope of factors that contribute to diagnostic error 1,9,45 inspires a vision of a 
learning ecosystem that evolves from existing (often local) projects into networked learning 
communities and learning cycles.11 Beginning with projects that address diagnostic problems of interest 
that cause the greatest harm,46 an emergent, ecosystem approach builds on existing momentum to 
develop diverse multi-stakeholder learning communities that will optimize diagnosis for patients and 
providers. With dedication to broad and deep stakeholder involvement, learning communities will be 
well-equipped to govern learning cycles that are clinically meaningful, sensitive to patient needs, 
informed by good science from a variety of methodologies (including ML/AI in some cases), and safely 
implemented.47,48 
However, there are many steps to be taken before this vision can be actualized. First, the right 
stakeholders must be mobilized, and although our interviews show the potential for synergy, that 
conclusion needs to be validated by the members of the three communities. Our next step is to convene 
members of these three stakeholder communities. This convening will provide a space to network and 
prototype how to synergize these communities in an LHS around specific diagnostic problems. For 
example, it’s an opportunity to build a relationship between the IDx and ML/AI communities by helping 
IDx researchers understand better of the capacity of ML/AI work and creating space for ML/AI 
researchers to learn more about the IDx need.  
We view the LHS community’s role as one that provides a contextual framework that can help facilitate 
data collection, clinical translation, and a community of practice that can navigate the cultural barriers 
that the IDx movement faces. A large portion of the role of LHS advocates is to promote the 
development and adoption of a complete platform of infrastructural services. A complete sociotechnical 
infrastructure—to be built of policies, processes, and technologies, carried out by people—is the 
enabling force behind an ecosystem’s ability to grow in scope and scale. Existing example infrastructure 
components include D2K-enabling platforms that manage and share clinical data, such as PopMedNet,49–
52 and “Big Data” platforms and algorithmic toolkits that are routinely used by the ML/AI 
community.50,52,53 There are also many emerging components that support K2P, such as the Knowledge 
Grid (KGrid)—which stores health knowledge and generates tailored advice to drive practice 
change54,55—and standards that support interoperability of such services.56 On the other hand, there 
appears to be a great need for infrastructure that supports P2D. Diagnostic researchers are calling for 
better-structured reporting of diagnostic processes and outcomes that can support our understanding 
of the epidemiology of diagnostic errors and generate new answers to addressing these 
challenges.18,45,57 
Another major stakeholder component includes patients and patient advocacy and safety groups. These 
groups are well positioned to be particularly effective in building a business case—or other, policy-based 
incentives—for HCOs and insurers to support this work. For example, can these groups work with payers 
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to advocate for improved timeliness and communication? Could they support research that studies the 
outcomes of diagnostic excellence efforts to help incentivize HCOs? Momentum around particular 
causes of diagnostic harm, and the motivation to address specific areas of diagnostic scope, are a crucial 
first step to activating stakeholders of medical diagnosis. 
It has been said that if one has one hour to save the world, the first fifty-five minutes should be spent 
defining the problem. Diagnosis is a critical point in the treatment path, and it follows that systems 
should assess diagnostic processes for opportunities to optimize patient outcomes. Yet, for reasons that 
were illuminated in our interviews, cutting edge innovations in ML/AI and process improvements 
anchored in LHS approaches have disproportionately focused on treatment and quality, without 
corresponding investments toward realizing diagnostic excellence. Bringing together and systematically 
learning from thought leaders from these two communities and from the IDx community represented a 
catalytic first step in conceptualizing an LHS ecosystem for diagnostic excellence. These interviews 
taught us not only that none of the three communities alone can do the work at hand, but also that co-
creating a sociotechnical infrastructure is required to realize economies of scale and scope that will 
underpin the envisioned transformation. However, these lessons only just begin to illuminate our path 
forward. The work ahead requires collaboration among thought leaders from these three communities 
as well as patient and healthcare stakeholders.  To plot the path forward and advance on the shared 
journey, these individuals and organizations will need to work together to map out what needs to be 
done, where components already exist that can be readily adapted to support it, and what must be built 
anew to fill the existing gaps. Doing so promises to advance our health system forward in realizing the 
big, hairy, audacious goal (BHAG) of achieving diagnostic excellence to improve the health of all 
members of society. 
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